Express your Opinion:  https://bit.ly/oppose-skin-cancer-medicare-cuts

Learn more:  https://bit.ly/medicare-cuts-skin-cancer

The landscape of healthcare in the United States is ever-evolving, with policy changes and budget reallocations frequently impacting the coverage and services available to millions. Recently, the Centers for Medicare & Medicaid Services (CMS) announced significant cuts to Medicare coverage, specifically affecting seniors battling non-melanoma skin cancer. This decision has sparked concern among healthcare professionals, patients, and advocacy groups alike. Understanding the implications of these cuts is crucial for affected individuals and their families, as well as for policymakers aiming to address the needs of our aging population.

Non-melanoma skin cancers, primarily basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are among the most common cancers diagnosed in the United States. While often less aggressive than melanoma, these cancers can lead to severe health complications if not treated appropriately. CMS's recent decision to reduce Medicare coverage for therapies related to non-melanoma skin cancer has raised alarms for several reasons.

If you're enjoying the Show, it would mean the world to us if you took a second to leave a five star review on YouTube, Apple Podcasts, or Spotify, or wherever you're listening to us. It helps more people find the show and lets us know we're on the right track. We thank you in advance

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.